AEG-41174

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAEG-41174
Drug Alias NameLS-104AEG-41174
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBcr-Abl tyrosine kinase inhibitorsTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK2Bcr-Abl tyrosine kinase
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe Hospital For Sick Children
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Hospital For Sick ChildrenAegerion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A